Financing, a drug candidate entering a trial, and clinical results each start a different clock.
Isomorphic Labs announced a $5 billion Series C on November 17. Greenoaks and Sequoia co-led the round, with Alphabet among the investors continuing to back the company. The company says it will expand its proprietary design system and candidate pipeline, and build development infrastructure as it advances candidates toward clinical trials. Its release reports preclinical progress. Isomorphic Labs financing announcement
How to track the next clinical milestone
Keep three milestones on a pipeline chart. The financing announcement records capital raised. A public trial record can establish a named candidate, study phase, and recruitment status. A completed study with results supplies evidence about the intervention in people. Follow-up on any specific drug should start at the relevant milestone rather than using the round size as a proxy.



